APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dementia Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dementia Drugs Industry Growth and Trends Forecast to 2032

22 December 2025112 pages

Choose your research edition.

Industry ResearchDementia Drugs Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Dementia Drugs Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Dementia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dementia Drugs Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Dementia Drugs Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Dementia Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dementia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dementia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dementia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dementia Drugs include Janssen Pharmaceuticals, Inc, Eisai, Inc, Teva Pharmaceuticals Industries, Sanofi S.A, Johnson and Johnson, Novartis AG, Eli Lilly and Company, Pfizer Inc and Abbvie Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dementia Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dementia Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dementia Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dementia Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dementia Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dementia Drugs Market by Company

Janssen Pharmaceuticals, Inc

Eisai, Inc

Teva Pharmaceuticals Industries

Sanofi S.A

Johnson and Johnson

Novartis AG

Eli Lilly and Company

Pfizer Inc

Abbvie Inc

AstraZeneca GmbH

Zydus Cadila

Valeant Pharmaceutical International

Merck & Co., Inc

Forest Laboratories, Inc

F. Hoffmann-La Roche

Biogen Pharmaceuticals

Aurobindo Pharma

Apotex inc.

Dementia Drugs Segment by Type

Glutamate Inhibitors

Cholinesterase Inhibitors

MAO Inhibitors

Dementia Drugs Segment by Application

Hospital Pharmacies

Retail Pharmacies

Others

Dementia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dementia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dementia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dementia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dementia Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dementia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Glutamate Inhibitors Table 2. Major Company of Cholinesterase Inhibitors Table 3. Major Company of MAO Inhibitors Table 4. Global Dementia Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Dementia Drugs Sales by Type (2021-2026) & (k units) Table 6. Global Dementia Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Dementia Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Dementia Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Dementia Drugs Price by Type (2021-2026) & (US$/unit) Table 10. Global Dementia Drugs Sales by Type (2027-2032) & (k units) Table 11. Global Dementia Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Dementia Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Dementia Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Dementia Drugs Price by Type (2027-2032) & (US$/unit) Table 15. North America Dementia Drugs Sales by Type (2021-2026) & (k units) Table 16. North America Dementia Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Dementia Drugs Sales by Type (2021-2026) & (k units) Table 18. Europe Dementia Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Dementia Drugs Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Dementia Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Dementia Drugs Sales by Type (2021-2026) & (k units) Table 22. Latin America Dementia Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Dementia Drugs Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Dementia Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Dementia Drugs Industry Trends Table 26. Dementia Drugs Industry Drivers Table 27. Dementia Drugs Industry Opportunities and Challenges Table 28. Dementia Drugs Industry Restraints Table 29. Global Dementia Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Dementia Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Dementia Drugs Sales by Company (2021-2026) & (k units) Table 32. Global Dementia Drugs Sales Share by Company (2021-2026) Table 33. Global Dementia Drugs Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Dementia Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Dementia Drugs Major Company Production Sites and Headquarters Table 36. Global Dementia Drugs Company, Product Type & Application Table 37. Global Dementia Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Dementia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Dementia Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Dementia Drugs Sales by Region (2021-2026) & (k units) Table 42. Global Dementia Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Dementia Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Dementia Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Dementia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Dementia Drugs Sales by Region (2027-2032) & (k units) Table 47. Global Dementia Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Dementia Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Dementia Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Dementia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Dementia Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Dementia Drugs Sales by Application (2021-2026) & (k units) Table 53. Global Dementia Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Dementia Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Dementia Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Dementia Drugs Price by Application (2021-2026) & (US$/unit) Table 57. Global Dementia Drugs Sales by Application (2027-2032) & (k units) Table 58. Global Dementia Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Dementia Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Dementia Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Dementia Drugs Price by Application (2027-2032) & (US$/unit) Table 62. North America Dementia Drugs Sales by Application (2021-2026) & (k units) Table 63. North America Dementia Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Dementia Drugs Sales by Application (2021-2026) & (k units) Table 65. Europe Dementia Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Dementia Drugs Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Dementia Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Dementia Drugs Sales by Application (2021-2026) & (k units) Table 69. Latin America Dementia Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Dementia Drugs Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Dementia Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Janssen Pharmaceuticals, Inc Company Information Table 73. Janssen Pharmaceuticals, Inc Business Overview Table 74. Janssen Pharmaceuticals, Inc Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Janssen Pharmaceuticals, Inc Dementia Drugs Product Portfolio Table 76. Janssen Pharmaceuticals, Inc Recent Development Table 77. Eisai, Inc Company Information Table 78. Eisai, Inc Business Overview Table 79. Eisai, Inc Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Eisai, Inc Dementia Drugs Product Portfolio Table 81. Eisai, Inc Recent Development Table 82. Teva Pharmaceuticals Industries Company Information Table 83. Teva Pharmaceuticals Industries Business Overview Table 84. Teva Pharmaceuticals Industries Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Teva Pharmaceuticals Industries Dementia Drugs Product Portfolio Table 86. Teva Pharmaceuticals Industries Recent Development Table 87. Sanofi S.A Company Information Table 88. Sanofi S.A Business Overview Table 89. Sanofi S.A Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Sanofi S.A Dementia Drugs Product Portfolio Table 91. Sanofi S.A Recent Development Table 92. Johnson and Johnson Company Information Table 93. Johnson and Johnson Business Overview Table 94. Johnson and Johnson Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Johnson and Johnson Dementia Drugs Product Portfolio Table 96. Johnson and Johnson Recent Development Table 97. Novartis AG Company Information Table 98. Novartis AG Business Overview Table 99. Novartis AG Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Novartis AG Dementia Drugs Product Portfolio Table 101. Novartis AG Recent Development Table 102. Eli Lilly and Company Company Information Table 103. Eli Lilly and Company Business Overview Table 104. Eli Lilly and Company Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Eli Lilly and Company Dementia Drugs Product Portfolio Table 106. Eli Lilly and Company Recent Development Table 107. Pfizer Inc Company Information Table 108. Pfizer Inc Business Overview Table 109. Pfizer Inc Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Pfizer Inc Dementia Drugs Product Portfolio Table 111. Pfizer Inc Recent Development Table 112. Abbvie Inc Company Information Table 113. Abbvie Inc Business Overview Table 114. Abbvie Inc Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Abbvie Inc Dementia Drugs Product Portfolio Table 116. Abbvie Inc Recent Development Table 117. AstraZeneca GmbH Company Information Table 118. AstraZeneca GmbH Business Overview Table 119. AstraZeneca GmbH Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. AstraZeneca GmbH Dementia Drugs Product Portfolio Table 121. AstraZeneca GmbH Recent Development Table 122. Zydus Cadila Company Information Table 123. Zydus Cadila Business Overview Table 124. Zydus Cadila Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Zydus Cadila Dementia Drugs Product Portfolio Table 126. Zydus Cadila Recent Development Table 127. Valeant Pharmaceutical International Company Information Table 128. Valeant Pharmaceutical International Business Overview Table 129. Valeant Pharmaceutical International Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Valeant Pharmaceutical International Dementia Drugs Product Portfolio Table 131. Valeant Pharmaceutical International Recent Development Table 132. Merck & Co., Inc Company Information Table 133. Merck & Co., Inc Business Overview Table 134. Merck & Co., Inc Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Merck & Co., Inc Dementia Drugs Product Portfolio Table 136. Merck & Co., Inc Recent Development Table 137. Forest Laboratories, Inc Company Information Table 138. Forest Laboratories, Inc Business Overview Table 139. Forest Laboratories, Inc Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Forest Laboratories, Inc Dementia Drugs Product Portfolio Table 141. Forest Laboratories, Inc Recent Development Table 142. F. Hoffmann-La Roche Company Information Table 143. F. Hoffmann-La Roche Business Overview Table 144. F. Hoffmann-La Roche Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 145. F. Hoffmann-La Roche Dementia Drugs Product Portfolio Table 146. F. Hoffmann-La Roche Recent Development Table 147. Biogen Pharmaceuticals Company Information Table 148. Biogen Pharmaceuticals Business Overview Table 149. Biogen Pharmaceuticals Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 150. Biogen Pharmaceuticals Dementia Drugs Product Portfolio Table 151. Biogen Pharmaceuticals Recent Development Table 152. Aurobindo Pharma Company Information Table 153. Aurobindo Pharma Business Overview Table 154. Aurobindo Pharma Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 155. Aurobindo Pharma Dementia Drugs Product Portfolio Table 156. Aurobindo Pharma Recent Development Table 157. Apotex inc. Company Information Table 158. Apotex inc. Business Overview Table 159. Apotex inc. Dementia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 160. Apotex inc. Dementia Drugs Product Portfolio Table 161. Apotex inc. Recent Development Table 162. North America Dementia Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 163. North America Dementia Drugs Sales by Country (2021-2026) & (k units) Table 164. North America Dementia Drugs Sales Market Share by Country (2021-2026) Table 165. North America Dementia Drugs Sales Forecast by Country (2027-2032) & (k units) Table 166. North America Dementia Drugs Sales Market Share Forecast by Country (2027-2032) Table 167. North America Dementia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. North America Dementia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 169. North America Dementia Drugs Market Share by Country (2021-2026) Table 170. North America Dementia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. North America Dementia Drugs Market Share Forecast by Country (2027-2032) Table 172. Europe Dementia Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 173. Europe Dementia Drugs Sales by Country (2021-2026) & (k units) Table 174. Europe Dementia Drugs Sales Market Share by Country (2021-2026) Table 175. Europe Dementia Drugs Sales Forecast by Country (2027-2032) & (k units) Table 176. Europe Dementia Drugs Sales Market Share Forecast by Country (2027-2032) Table 177. Europe Dementia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Europe Dementia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 179. Europe Dementia Drugs Market Share by Country (2021-2026) Table 180. Europe Dementia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Europe Dementia Drugs Market Share Forecast by Country (2027-2032) Table 182. Asia-Pacific Dementia Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 183. Asia-Pacific Dementia Drugs Sales by Country (2021-2026) & (k units) Table 184. Asia-Pacific Dementia Drugs Sales Market Share by Country (2021-2026) Table 185. Asia-Pacific Dementia Drugs Sales Forecast by Country (2027-2032) & (k units) Table 186. Asia-Pacific Dementia Drugs Sales Market Share Forecast by Country (2027-2032) Table 187. Asia-Pacific Dementia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Asia-Pacific Dementia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 189. Asia-Pacific Dementia Drugs Market Share by Country (2021-2026) Table 190. Asia-Pacific Dementia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Asia-Pacific Dementia Drugs Market Share Forecast by Country (2027-2032) Table 192. Latin America Dementia Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 193. Latin America Dementia Drugs Sales by Country (2021-2026) & (k units) Table 194. Latin America Dementia Drugs Sales Market Share by Country (2021-2026) Table 195. Latin America Dementia Drugs Sales Forecast by Country (2027-2032) & (k units) Table 196. Latin America Dementia Drugs Sales Market Share Forecast by Country (2027-2032) Table 197. Latin America Dementia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Latin America Dementia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 199. Latin America Dementia Drugs Market Share by Country (2021-2026) Table 200. Latin America Dementia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Latin America Dementia Drugs Market Share Forecast by Country (2027-2032) Table 202. Middle East and Africa Dementia Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 203. Middle East and Africa Dementia Drugs Sales by Country (2021-2026) & (k units) Table 204. Middle East and Africa Dementia Drugs Sales Market Share by Country (2021-2026) Table 205. Middle East and Africa Dementia Drugs Sales Forecast by Country (2027-2032) & (k units) Table 206. Middle East and Africa Dementia Drugs Sales Market Share Forecast by Country (2027-2032) Table 207. Middle East and Africa Dementia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 208. Middle East and Africa Dementia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 209. Middle East and Africa Dementia Drugs Market Share by Country (2021-2026) Table 210. Middle East and Africa Dementia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 211. Middle East and Africa Dementia Drugs Market Share Forecast by Country (2027-2032) Table 212. Key Raw Materials Table 213. Raw Materials Key Suppliers Table 214. Dementia Drugs Distributors List Table 215. Dementia Drugs Customers List Table 216. Research Programs/Design for This Report Table 217. Authors List of This Report Table 218. Secondary Sources Table 219. Primary Sources List of Figures Figure 1. Dementia Drugs Image Figure 2. Global Dementia Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dementia Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Dementia Drugs Sales (2021-2032) & (k units) Figure 5. Glutamate Inhibitors Image Figure 6. Global Glutamate Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 7. Cholinesterase Inhibitors Image Figure 8. Global Cholinesterase Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 9. MAO Inhibitors Image Figure 10. Global MAO Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Dementia Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Dementia Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Dementia Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Dementia Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Dementia Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Dementia Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Dementia Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Dementia Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Dementia Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Dementia Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Dementia Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Dementia Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Dementia Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Pharmacies Image Figure 26. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 27. Retail Pharmacies Image Figure 28. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Dementia Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Dementia Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Dementia Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Dementia Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Dementia Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Dementia Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Dementia Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Dementia Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Dementia Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Dementia Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Dementia Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Dementia Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Dementia Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Dementia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Dementia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Dementia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Dementia Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Dementia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Dementia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Dementia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Dementia Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Dementia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Dementia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Dementia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Dementia Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Dementia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Dementia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Dementia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Dementia Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Dementia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Dementia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Dementia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Dementia Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Dementia Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Glutamate Inhibitors
  • Cholinesterase Inhibitors
  • MAO Inhibitors
Applications
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Janssen Pharmaceuticals, Inc
  • Eisai, Inc
  • Teva Pharmaceuticals Industries
  • Sanofi S.A
  • Johnson and Johnson
  • Novartis AG
  • Eli Lilly and Company
  • Pfizer Inc
  • Abbvie Inc
  • AstraZeneca GmbH
  • Zydus Cadila
  • Valeant Pharmaceutical International
  • Merck & Co., Inc
  • Forest Laboratories, Inc
  • F. Hoffmann-La Roche
  • Biogen Pharmaceuticals
  • Aurobindo Pharma
  • Apotex inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dementia Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dementia Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dementia Drugs Market by Type
  6. 1.3.1 Glutamate Inhibitors
  7. 1.3.2 Cholinesterase Inhibitors
  8. 1.3.3 MAO Inhibitors
  9. 1.4 Global Dementia Drugs Market Size by Type
  10. 1.4.1 Global Dementia Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Dementia Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Dementia Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Dementia Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Dementia Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Dementia Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Dementia Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Dementia Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dementia Drugs Industry Trends
  2. 2.2 Dementia Drugs Industry Drivers
  3. 2.3 Dementia Drugs Industry Opportunities and Challenges
  4. 2.4 Dementia Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dementia Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Dementia Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Dementia Drugs Price (2021-2026)
  4. 3.4 Global Dementia Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dementia Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Dementia Drugs Company, Product Type & Application
  7. 3.7 Global Dementia Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dementia Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dementia Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dementia Drugs Tier 1, Tier 2, and Tier 3
4 Dementia Drugs Regional Status and Outlook
  1. 4.1 Global Dementia Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dementia Drugs Historic Market Size by Region
  3. 4.2.1 Global Dementia Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dementia Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dementia Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dementia Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Dementia Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dementia Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dementia Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dementia Drugs by Application
  1. 5.1 Dementia Drugs Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Others
  5. 5.2 Global Dementia Drugs Market Size by Application
  6. 5.2.1 Global Dementia Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Dementia Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Dementia Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Dementia Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Dementia Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Dementia Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Dementia Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Dementia Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Janssen Pharmaceuticals, Inc
  2. 6.1.1 Janssen Pharmaceuticals, Inc Company Information
  3. 6.1.2 Janssen Pharmaceuticals, Inc Business Overview
  4. 6.1.3 Janssen Pharmaceuticals, Inc Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Janssen Pharmaceuticals, Inc Dementia Drugs Product Portfolio
  6. 6.1.5 Janssen Pharmaceuticals, Inc Recent Developments
  7. 6.2 Eisai, Inc
  8. 6.2.1 Eisai, Inc Company Information
  9. 6.2.2 Eisai, Inc Business Overview
  10. 6.2.3 Eisai, Inc Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eisai, Inc Dementia Drugs Product Portfolio
  12. 6.2.5 Eisai, Inc Recent Developments
  13. 6.3 Teva Pharmaceuticals Industries
  14. 6.3.1 Teva Pharmaceuticals Industries Company Information
  15. 6.3.2 Teva Pharmaceuticals Industries Business Overview
  16. 6.3.3 Teva Pharmaceuticals Industries Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Teva Pharmaceuticals Industries Dementia Drugs Product Portfolio
  18. 6.3.5 Teva Pharmaceuticals Industries Recent Developments
  19. 6.4 Sanofi S.A
  20. 6.4.1 Sanofi S.A Company Information
  21. 6.4.2 Sanofi S.A Business Overview
  22. 6.4.3 Sanofi S.A Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi S.A Dementia Drugs Product Portfolio
  24. 6.4.5 Sanofi S.A Recent Developments
  25. 6.5 Johnson and Johnson
  26. 6.5.1 Johnson and Johnson Company Information
  27. 6.5.2 Johnson and Johnson Business Overview
  28. 6.5.3 Johnson and Johnson Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Johnson and Johnson Dementia Drugs Product Portfolio
  30. 6.5.5 Johnson and Johnson Recent Developments
  31. 6.6 Novartis AG
  32. 6.6.1 Novartis AG Company Information
  33. 6.6.2 Novartis AG Business Overview
  34. 6.6.3 Novartis AG Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis AG Dementia Drugs Product Portfolio
  36. 6.6.5 Novartis AG Recent Developments
  37. 6.7 Eli Lilly and Company
  38. 6.7.1 Eli Lilly and Company Company Information
  39. 6.7.2 Eli Lilly and Company Business Overview
  40. 6.7.3 Eli Lilly and Company Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Eli Lilly and Company Dementia Drugs Product Portfolio
  42. 6.7.5 Eli Lilly and Company Recent Developments
  43. 6.8 Pfizer Inc
  44. 6.8.1 Pfizer Inc Company Information
  45. 6.8.2 Pfizer Inc Business Overview
  46. 6.8.3 Pfizer Inc Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Inc Dementia Drugs Product Portfolio
  48. 6.8.5 Pfizer Inc Recent Developments
  49. 6.9 Abbvie Inc
  50. 6.9.1 Abbvie Inc Company Information
  51. 6.9.2 Abbvie Inc Business Overview
  52. 6.9.3 Abbvie Inc Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Abbvie Inc Dementia Drugs Product Portfolio
  54. 6.9.5 Abbvie Inc Recent Developments
  55. 6.10 AstraZeneca GmbH
  56. 6.10.1 AstraZeneca GmbH Company Information
  57. 6.10.2 AstraZeneca GmbH Business Overview
  58. 6.10.3 AstraZeneca GmbH Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AstraZeneca GmbH Dementia Drugs Product Portfolio
  60. 6.10.5 AstraZeneca GmbH Recent Developments
  61. 6.11 Zydus Cadila
  62. 6.11.1 Zydus Cadila Company Information
  63. 6.11.2 Zydus Cadila Business Overview
  64. 6.11.3 Zydus Cadila Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Zydus Cadila Dementia Drugs Product Portfolio
  66. 6.11.5 Zydus Cadila Recent Developments
  67. 6.12 Valeant Pharmaceutical International
  68. 6.12.1 Valeant Pharmaceutical International Company Information
  69. 6.12.2 Valeant Pharmaceutical International Business Overview
  70. 6.12.3 Valeant Pharmaceutical International Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Valeant Pharmaceutical International Dementia Drugs Product Portfolio
  72. 6.12.5 Valeant Pharmaceutical International Recent Developments
  73. 6.13 Merck & Co., Inc
  74. 6.13.1 Merck & Co., Inc Company Information
  75. 6.13.2 Merck & Co., Inc Business Overview
  76. 6.13.3 Merck & Co., Inc Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Merck & Co., Inc Dementia Drugs Product Portfolio
  78. 6.13.5 Merck & Co., Inc Recent Developments
  79. 6.14 Forest Laboratories, Inc
  80. 6.14.1 Forest Laboratories, Inc Company Information
  81. 6.14.2 Forest Laboratories, Inc Business Overview
  82. 6.14.3 Forest Laboratories, Inc Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Forest Laboratories, Inc Dementia Drugs Product Portfolio
  84. 6.14.5 Forest Laboratories, Inc Recent Developments
  85. 6.15 F. Hoffmann-La Roche
  86. 6.15.1 F. Hoffmann-La Roche Company Information
  87. 6.15.2 F. Hoffmann-La Roche Business Overview
  88. 6.15.3 F. Hoffmann-La Roche Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 F. Hoffmann-La Roche Dementia Drugs Product Portfolio
  90. 6.15.5 F. Hoffmann-La Roche Recent Developments
  91. 6.16 Biogen Pharmaceuticals
  92. 6.16.1 Biogen Pharmaceuticals Company Information
  93. 6.16.2 Biogen Pharmaceuticals Business Overview
  94. 6.16.3 Biogen Pharmaceuticals Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Biogen Pharmaceuticals Dementia Drugs Product Portfolio
  96. 6.16.5 Biogen Pharmaceuticals Recent Developments
  97. 6.17 Aurobindo Pharma
  98. 6.17.1 Aurobindo Pharma Company Information
  99. 6.17.2 Aurobindo Pharma Business Overview
  100. 6.17.3 Aurobindo Pharma Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Aurobindo Pharma Dementia Drugs Product Portfolio
  102. 6.17.5 Aurobindo Pharma Recent Developments
  103. 6.18 Apotex inc.
  104. 6.18.1 Apotex inc. Company Information
  105. 6.18.2 Apotex inc. Business Overview
  106. 6.18.3 Apotex inc. Dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Apotex inc. Dementia Drugs Product Portfolio
  108. 6.18.5 Apotex inc. Recent Developments
7 North America by Country
  1. 7.1 North America Dementia Drugs Sales by Country
  2. 7.1.1 North America Dementia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dementia Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Dementia Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dementia Drugs Market Size by Country
  6. 7.2.1 North America Dementia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dementia Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Dementia Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dementia Drugs Sales by Country
  2. 8.1.1 Europe Dementia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dementia Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Dementia Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dementia Drugs Market Size by Country
  6. 8.2.1 Europe Dementia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dementia Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dementia Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dementia Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Dementia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dementia Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dementia Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dementia Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Dementia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dementia Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dementia Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dementia Drugs Sales by Country
  2. 10.1.1 South America Dementia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dementia Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Dementia Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dementia Drugs Market Size by Country
  6. 10.2.1 South America Dementia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dementia Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Dementia Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dementia Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Dementia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dementia Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dementia Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dementia Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Dementia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dementia Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dementia Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dementia Drugs Value Chain Analysis
  2. 12.1.1 Dementia Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dementia Drugs Production Mode & Process
  7. 12.2 Dementia Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dementia Drugs Distributors
  10. 12.2.3 Dementia Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst